S. Apte

发表

In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival

R. Wenham, J. Gonzalez-Bosquet, N. Chen, 2012, British Journal of Cancer.

A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer.

R. Iyer, S. Apte, J. Wolf, 2009, Gynecologic oncology.

Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.

J. Lancaster, R. Wenham, Y. Xiong, 2016, Gynecologic oncology.

Cervical cancer.

Kathleen R. Cho, M. Morgan, N. Dupont, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Targeting the Platelet-Derived Growth Factor Receptor in Antivascular Therapy for Human Ovarian Carcinoma

I. Fidler, S. Apte, D. Fan, 2004, Clinical Cancer Research.

Society of gynecologic oncology future of physician payment reform task force: Lessons learned in developing and implementing surgical alternative payment models.

Jason D. Wright, L. Havrilesky, E. Ko, 2020, Gynecologic oncology.

Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines.

C. Bucana, I. Fidler, S. Apte, 2004, Gynecologic oncology.

A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy.

J. Lancaster, R. Wenham, J. Gonzalez-Bosquet, 2011, Gynecologic oncology.

A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

R. Iyer, S. Apte, J. Wolf, 2014 .

The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer.

J. Lancaster, R. Wenham, J. Gonzalez-Bosquet, 2012, International journal of oncology.

Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes

R. Wenham, J. Lancaster, D. Marchion, 2021, bioRxiv.

Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.

J. Lancaster, R. Wenham, D. Marchion, 2021, PloS one.

The use of minimally invasive surgery for endometrial cancer.

Mary M. Humphrey, S. Apte, 2009, Cancer control : journal of the Moffitt Cancer Center.

Uterus Cervix of uterus Vagina Ovary Fallopian tube Sagittal section Fallopian tube with ovary Uterus Bladder Vagina Urethra Cervix of uterus Rectum

Mary M. Humphrey, S. Apte, 2008 .

Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines.

Kathleen R. Cho, D. Mutch, A. Mariani, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Electrothermal bipolar coagulation decreases the rate of red blood cell transfusions for pelvic exenterations

J. Lancaster, R. Wenham, N. Bansal, 2009, Journal of surgical oncology.

Cervical cancer.

Kathleen R. Cho, M. Morgan, N. Dupont, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Twenty-year surgical trends in a gynecologic oncology fellowship training program: Implications for practice.

R. Wenham, Y. Xiong, S. Apte, 2019, Gynecologic oncology.

Uterine neoplasms, version 1.2014.

Kathleen R. Cho, N. Dupont, D. Mutch, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity.

R. Wenham, D. Hunt, H. Chon, 2019, Gynecologic oncology.

Cervical cancer: Clinical practice guidelines in oncology

Kathleen R. Cho, M. Morgan, N. Dupont, 2013 .

Gedunin, a Novel Natural Substance, Inhibits Ovarian Cancer Cell Proliferation

J. Lancaster, R. Wenham, N. Chen, 2009, International Journal of Gynecologic Cancer.

Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel.

Suyun Huang, I. Fidler, Suyun Huang, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

NTRK-1 fusion in endocervical fibroblastic malignant peripheral nerve sheath tumor marking eligibility for larotrectinib therapy: A case report

M. Bui, S. Apte, D. Reed, 2019, Gynecologic oncology reports.

Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix

R. Wenham, H. Chon, S. Apte, 2015, International Journal of Gynecologic Cancer.

Cervical cancer, version 2.2015: Featured updates to the NCCN guidelines featured updates to the NCCN guidelines

Kathleen R. Cho, D. Mutch, Nicole R. McMillian, 2015 .

BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

S. Eschrich, A. Berchuck, J. Lancaster, 2011, Clinical Cancer Research.

Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.

J. Lancaster, R. Wenham, J. Gonzalez-Bosquet, 2016, Oncology letters.

MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

H. Dressman, J. Lancaster, R. Wenham, 2008, Gynecologic oncology.

Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers

R. Wenham, H. Chon, S. Apte, 2017, BMC Cancer.

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin

J. Lancaster, R. Wenham, J. Gonzalez-Bosquet, 2012, Journal of gynecologic oncology.

Predictive Biomarkers and Personalized Medicine BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

S. Eschrich, A. Berchuck, J. Lancaster, 2011 .

Category : Predictive Biomarkers and Personalized Medicine BAD phosphorylation determines ovarian cancer chemo-sensitivity and patient survival

S. Eschrich, A. Berchuck, J. Lancaster, 2011 .

Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin.

J. Lancaster, R. Wenham, Y. Xiong, 2010, American journal of obstetrics and gynecology.

BAD-mediated apoptotic pathway is associated with human cancer development

J. Lancaster, R. Wenham, E. Biçaku, 2015, International journal of molecular medicine.

Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel

T. Sellers, J. Lancaster, R. Wenham, 2013, Oncology reports.

MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.

H. Dressman, J. Lancaster, R. Wenham, 2009, Gynecologic oncology.

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

J. Lancaster, R. Wenham, J. Gonzalez-Bosquet, 2013, Oncology reports.

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer.

J. Lancaster, R. Wenham, J. Gonzalez-Bosquet, 2013, American journal of obstetrics and gynecology.

The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.

J. Lancaster, R. Wenham, J. Gonzalez-Bosquet, 2012, Gynecologic oncology.

Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin

R. Iyer, S. Apte, P. Ramirez, 2006, Journal of Translational Medicine.

Cervical Cancer, Version 2.2015.

R Kevin Reynolds, Kathleen R. Cho, Peter Frederick, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Characterizing the Efficacy of Fermented Wheat Germ Extract Against Ovarian Cancer and Defining the Genomic Basis of Its Activity

J. Lancaster, R. Wenham, J. Gonzalez-Bosquet, 2012, International Journal of Gynecologic Cancer.

Regional cooling significantly reduces liposomal doxorubicin-induced palmar-plantar erythrodysesthesias (PPE) in patients with recurrent ovarian cancer.

R. Sayer, S. Apte, S. Tedjarati, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endometrial carcinoma associated with pregnancy: A report of three cases and review of the literature.

S. Rubin, S. Apte, L. Copeland, 1999, Gynecologic oncology.

The role of surgery in the management of epithelial ovarian cancer.

H. Chon, S. Apte, I. Ramirez, 2011, Cancer control : journal of the Moffitt Cancer Center.

Surgery remains key in the diagnosis , staging , and management of ovarian cancer . The Role of Surgery in the Management of Epithelial Ovarian Cancer

H. Chon, S. Apte, I. Ramirez, 2010 .

Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.

J. Lancaster, R. Wenham, L. Havrilesky, 2016, Molecular and clinical oncology.

Gene expression profiling of 389 endometrioid endometrial carcinomas reveals 4 distinct molecular subtypes

Y. Xiong, D. Marchion, H. Chon, 2016 .

Unique molecular portraits of ovarian cancer: Implications for prognostics and targeted therapeutics

J. Lancaster, Y. Xiong, D. Marchion, 2015 .

Metastatic VIPoma presenting as an ovarian mass

S. Apte, S. Bush, J. Strosberg, 2015, International journal of surgery case reports.

Robotic-Assisted Surgery in Gynecological Oncology.

S. Apte, S. Bush, 2015, Cancer control : journal of the Moffitt Cancer Center.

Payment Reform: Unprecedented and Evolving Impact on Gynecologic Oncology

Kavita K. Patel, S. Apte, 2016, Front. Oncol..

Dual antibiotic prevention bundle is associated with decreased surgical site infections

D. Boulware, S. Apte, R. Vargas, 2020, International Journal of Gynecological Cancer.

A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer.

H. Jim, B. Small, H. Chon, 2019, Gynecologic oncology.

Fatigue, Depression, Sleep, and Activity During Chemotherapy: Daily and Intraday Variation and Relationships Among Symptom Changes

H. Jim, P. Jacobsen, B. Small, 2011, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Hemapoietic, immunomodulatory, antitumor, and toxicity profiles of sequential GM-CSF and IFNγ1b biotherapy and carboplatin in recurrent ovarian carcinoma

R. Iyer, Y. Yang, S. Apte, 2005 .

Cumulative burden of symptomatology in patients with gynecologic malignancies undergoing chemotherapy.

H. Jim, B. Small, H. Chon, 2022, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison

R. Wenham, H. Jim, J. Bower, 2023, Cancers.

Evaluation of the porcine model to teach various ancillary procedures to gynecologic oncology fellows.

R. Wenham, S. Apte, M. Shames, 2009, American journal of obstetrics and gynecology.

Psychosocial resources and sleep disturbance before chemotherapy for gynecologic cancer

H. Jim, P. Jacobsen, B. Small, 2016, Journal of psychosocial oncology.

Clinical and pathologic predictors of survival in patients with endometrial stromal sarcoma

Lesly A. Dossett, R. Wenham, R. Gonzalez, 2015 .

Phase II trial of dose dense (weekly) paclitaxel with pembrolizumab (MK-3475) in platinum-resistant recurrent ovarian cancer.

R. Wenham, H. Chon, S. Apte, 2016 .

Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies

R. Wenham, H. Jim, J. Bower, 2023, Cancers.

Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer

J. Lancaster, R. Wenham, Y. Xiong, 2018, American journal of obstetrics and gynecology.

Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest.

J. Lancaster, R. Wenham, Y. Xiong, 2013, Gynecologic oncology.

Factors associated with improved toxicity and tolerability of intraperitoneal chemotherapy in advanced-stage epithelial ovarian cancers.

J. Lancaster, R. Wenham, J. Gonzalez-Bosquet, 2013, American journal of obstetrics and gynecology.

Respiratory failure from metastatic choriocarcinoma: a survivor of mechanical ventilation.

S. Apte, P. Diaz, L. Copeland, 1997, Gynecologic oncology.